Fig. 1From: Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemicMolecular docking between callophysin A and 3CLpro in extra-precision (XP) mode. a 2D and b 3D representation of the binding mode of callophysin A to the active site of 3CLpro, c Interaction between callophysin A and active site residues, and d Interaction between 3CLpro and callophysin A, showing the involvement of different amino acid residues and the molecular forces between protein and inhibitorBack to article page